Drug intelligence / Profile preview

Yisui (Traditional Chinese Medicine formulation)

Development stage: Preclinical
Lead developer: Shandong University of Traditional Chinese Medicine
Administration: Oral

Overview

Yisui refers to a Traditional Chinese Medicine (TCM) formulation or method. In the context of the provided clinical trial, it is investigated for its role in the recovery of motor function and the level of Brain-Derived Neurotrophic Factor (BDNF) in patients with ischemic stroke. It is used in combination with Western medicine routine treatment, rehabilitation, and acupuncture. Traditional Chinese Medicine generally operates on the principle of balancing the body's vital force, Qi, and its interconnectedness with natural elements to restore health.

Other names: Yisui methodTraditional Chinese medicine fujianfang treatment

Targets

ATF4 (Activating transcription factor 4)

Beyond the preview

Go deeper on Yisui (Traditional Chinese Medicine formulation).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yisui (Traditional Chinese Medicine formulation).

Explore the full profile